ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,314Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 252

$649K Total Retail Price of All Prescriptions

Rank: 62 out of 252

766 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 766 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 766 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 10,159 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 626 563 1 1
SIMVASTATIN 473 421 2 2
HYDROCODONE-ACETAMINOPHEN 463 315 S3 3 5
LISINOPRIL 417 367 4 3
PRAVASTATIN SODIUM 369 337 5 12
METFORMIN HCL 353 233 6 9
OMEPRAZOLE 329 273 7 6
ZOLPIDEM TARTRATE 309 223 8 21
HYDROCHLOROTHIAZIDE 263 217 9 13
AMLODIPINE BESYLATE 224 219 10 4
MELOXICAM 218 173 11 20
FUROSEMIDE 215 196 12 7
CITALOPRAM HBR 205 143 13 15
GABAPENTIN 204 166 14 11
WARFARIN SODIUM 185 174 15 14
POTASSIUM CHLORIDE 179 164 16 8
METOPROLOL TARTRATE 162 155 17 10
ATENOLOL 159 152 18 18
ATORVASTATIN CALCIUM 150 126 19 16
METOPROLOL SUCCINATE 145 125 20 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 131 111 21 25
NEXIUM 129 99 22 23
ALENDRONATE SODIUM 115 110 23 32
ALLOPURINOL 113 102 24 30
DILTIAZEM ER 96 80 25 86
TAMSULOSIN HCL 95 91 26 26
CARVEDILOL 94 85 27 22
SERTRALINE HCL 91 77 28 27
TRAMADOL HCL 88 65 29 17
CYCLOBENZAPRINE HCL 79 42 R 30 51
DOXAZOSIN MESYLATE 77 60 31 73
LOVASTATIN 76 73 32 39
GEMFIBROZIL 75 61 33 98
LOSARTAN POTASSIUM 72 66 34 24
POLYETHYLENE GLYCOL 3350 72 62 34 67
TRIAMTERENE-HCTZ 71 62 36 33
CYMBALTA 71 43 36 45
GLIPIZIDE 71 41 36 52
AMITRIPTYLINE HCL 69 42 R 39 46
AMLODIPINE BESYLATE-BENAZEPRIL 68 55 40 60
LOSARTAN-HYDROCHLOROTHIAZIDE 68 60 40 49
PANTOPRAZOLE SODIUM 68 62 40 62
DONEPEZIL HCL 67 65 43 28
TRAZODONE HCL 66 47 44 31
CARISOPRODOL 65 16 R 45 70
ISOSORBIDE MONONITRATE ER 65 51 45 50
PEN NEEDLE 62 58 47 140
DIOVAN 61 60 48 38
KLOR-CON M20 59 46 49 69
CELEBREX 59 54 49 101
BENICAR 56 46 51 143
VERAPAMIL ER 55 55 52 83
FINASTERIDE 55 55 52 115
LANTUS 54 54 54 55
ESTRADIOL 54 48 R 54 76
PLAVIX 52 40 56 43
CLOPIDOGREL 51 38 57 29
DILTIAZEM 24HR CD 50 42 58 104
BENAZEPRIL HCL 50 37 58 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 25, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.